Gastrointestinal Complications Following Transplantation

Surgical Clinics of North America

Volumn 86, Issue 5, 2006, Pages 1195-1206

  Gautam, Amitabh ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN; AZITHROMYCIN; CASPOFUNGIN; CLOTRIMAZOLE; CORTICOSTEROID; CYCLOSPORIN; GANCICLOVIR; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; POLYSTYRENESULFONATE SODIUM; POSACONAZOLE; PROTON PUMP INHIBITOR; RAPAMYCIN; TACROLIMUS; VALGANCICLOVIR; VORICONAZOLE;

APHTHOUS STOMATITIS; BACTERIAL INFECTION; BILIARY TRACT DISEASE; CHOLECYSTECTOMY; CLINICAL TRIAL; COLON CANCER; COLON DISEASE; COLON PERFORATION; COLONOSCOPY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIGESTIVE SYSTEM CANCER; DIVERTICULOSIS; DRUG BIOAVAILABILITY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; ESOPHAGUS DISEASE; FUNGEMIA; GASTRODUODENAL ULCER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GRAFT REJECTION; HEART TRANSPLANTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HERPES SIMPLEX; HUMAN; HYPERKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LEUKOPLAKIA; LYMPHOPROLIFERATIVE DISEASE; MOUTH LESION; MOUTH ULCER; MYCOSIS; ORGAN TRANSPLANTATION; PARASITOSIS; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; SALMONELLA; STOMACH CANCER; THRUSH; TISSUE NECROSIS; VERRUCA VULGARIS; VIREMIA; VIRUS INFECTION; VIRUS REACTIVATION;

GASTROINTESTINAL DISEASES; HUMANS; IMMUNOSUPPRESSION; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 33748160073     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.06.006     Document Type: Review

References (56)

1. Hoekstra H.J., Hawkins K., de Boer W.J., et al. Gastrointestinal complications in lung transplant survivors that require surgical intervention. Br J Surg 88 (2001) 433-438
2. Sarkio S., Halme L., Kyllonen L., et al. Severe gastrointestinal complications after 1,515 adult kidney transplantations. Transplant Int 17 (2004) 505-510
3. Luckraz H., Goddard M., Charman S.C., et al. Early mortality after cardiac transplantation: should we do better?. J Heart Lung Transplant 24 (2005) 401-405
4. Goldberg H.J., Hertz M.I., Ricciardi R., et al. Colon and rectal complications after heart and lung transplantation. J Am Coll Surg 202 (2006) 55-61
5. Hyland P.L., Traynor P.S., Myrillas T.T., et al. The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol 74 (2003) 437-445
6. de la Rosa-Garcia E., Mondragon-Padilla A., Irigoyen-Camacho M.E., et al. Oral lesions in a group of kidney transplant patients. Med Oral Patol Oral Cir Bucal 10 (2005) 196-204
7. Nash M.M., and Zaltzman J.S. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 65 (1998) 1611-1615
8. van Gelder T., ter Meulen C.G., Hene R., et al. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil. Transplantation 75 (2003) 788-791
9. Seymour R.A., Thomason J.M., and Nolan A. Oral lesions in organ transplant patients. J Oral Pathol Med 26 (1997) 297-304
10. Owens M.L., Passaro E., Wilson S.E., et al. Treatment of peptic ulcer disease in the renal transplant patient. Ann Surg 186 (1977) 17-21
11. Nardone G., Rocco A., Fiorillo M., et al. Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter 10 (2005) 53-58
12. Helderman J.H. Prophylaxis and treatment of gastrointestinal complications following transplantation. Clin Transplant 15 S (2001) 29-35
13. Skala I., Mareckova O., Vitko S., et al. Prophylaxis of acute gastro duodenal bleeding after renal transplantation. Transplant Int 10 (1997) 375-378
14. Hosotani Y., Kawanami C., Hasegawa K., et al. A role of Helicobacter pylori infection in the development of duodenal ulcer after adult living-related liver transplantation. Transplantation 76 (2003) 702-704
15. Kasiske B.L., Cangro C.B., Hariharan S., et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 2 S (2001) 3-95
16. Steger A.C., Timoney A.S., Griffen S., et al. The influence of immunosuppression on peptic ulceration following renal transplantation and the role of endoscopy. Nephrol Dial Transplant 5 (1990) 289-292
17. Chen K.J., Chen C.H., Cheng C.H., et al. Risk factors for peptic ulcer disease in renal transplant patients-11 years of experience from a single center. Clin Nephrol 62 (2004) 14-20
18. Conn H.O., and Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 236 (1994) 619-632
19. Vega K.J., Pina I., and Krevsky B. Heart transplantation is associated with an increased risk for pancreaticobiliary disease. Ann Intern Med 124 (1996) 980-983
20. Gupta D., Sakorafas G.H., McGregor C.G., et al. Management of biliary tract disease in heart and lung transplant patients. Surgery 128 (2000) 641-649
21. Richardson W.S., Surowiec W.J., Carter K.M., et al. Gallstone disease in heart transplant recipients. Ann Surg 237 (2003) 273-276
22. Melvin W.S., Meier D.J., Elkhammas E.A., et al. Prophylactic cholecystectomy is not indicated following renal transplantation. Am J Surg 175 (1998) 317-319
23. Graham S.M., Flowers J.L., Schweitzer E., et al. The utility of prophylactic laparoscopic cholecystectomy in transplant candidates. Am J Surg 169 (1995) 44-49
24. Jackson T., Treleaven D., Arlen D., et al. Management of asymptomatic cholelithiasis for patients awaiting renal transplantation. Surg Endosc 19 (2005) 510-513
25. Kao L.S., Flowers C., and Flum D.R. Prophylactic cholecystectomy in transplant patients: a decision analysis. J Gastrointest Surg 9 (2005) 965-972
26. Penn I. Posttransplant malignancies. Transplant Proc 31 (1999) 1260-1262
27. Stewart T., Henderson R., Grayson H., et al. Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin Cancer Res 3 (1997) 51-55
28. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 S (2005) 5254-5264
29. Adami J., Gabel H., Lindelof B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89 (2003) 1221-1227
30. Sillman F.H., Sentovich S., and Shaffer D. Ano-genital neoplasia in renal transplant patients. Ann Transplant 2 (1997) 59-66
31. Swinnen L.J. Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 11 S (2000) 45-48
32. Rubin R.H. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities. Clin Transplant (2001) 15(S)4:11-22
33. Green M. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 1 (2001) 103-108
34. Savage P., and Waxman J. Post-transplantation lymphoproliferative disease. QJM 90 (1997) 497-503
35. Oertel S.H., Verschuuren E., Reinke P., et al. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 5 (2005) 2901-2906
36. Stelzner M., Vlahakos D.V., Milford E.L., et al. Colonic perforations after renal transplantation. J Am Coll Surg 184 (1997) 63-69
37. Bobak D.A. Gastrointestinal infections caused by cytomegalovirus. Curr Infect Dis Rep 5 (2003) 101-107
38. Lee C.J., Lian J.D., Chang S.W., et al. Lethal cytomegalovirus ischemic colitis presenting with fever of unknown origin. Transplant Infect Dis 6 (2004) 124-128
39. Koneru B., Selby R., O'Hair D.P., et al. Nonobstructing colonic dilatation and colon perforations following renal transplantation. Arch Surg 125 (1990) 610-613
40. Scott T.R., Graham S.M., Schweitzer E.J., et al. Colonic necrosis following sodium polystyrene sulfonate (Kayexalate)-sorbitol enema in a renal transplant patient. Report of a case and review of the literature. Dis Colon Rectum 36 (1993) 607-609
41. Gerstman B.B., Kirkman R., and Platt R. Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kidney Dis 20 (1992) 159-161
42. McCune T.R., Nylander W.A., Van Buren D.H., et al. Colonic screening prior to renal transplantation and its impact on post-transplant colonic complications. Clin Transplant 6 (1992) 91-96
43. Lederman E.D., McCoy G., Conti D.J., et al. Diverticulitis and polycystic kidney disease. Am Surg 66 (2000) 200-203
44. Stratta R.J. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation. Transplant Proc 25 S (1993) 15-21
45. Snydman D.R. Infection in solid organ transplantation. Transplant Infect Dis 1 (1999) 21-28
46. Rubin R.H. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 12 S (1990) S754-S766
47. Paya C., Humar A., Dominguez E., et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 4 (2004) 611-620
48. Slifkin M., Tempesti P., Poutsiaka D.D., et al. Late and atypical cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis 33 (2001) 62-68
49. Mosimann F., Cuenoud P.F., Steinhauslin F., et al. Herpes simplex esophagitis after renal transplantation. Transplant Int 7 (1994) 79-82
50. Patterson J.E. Epidemiology of fungal infections in solid organ transplant patients. Transplant Infect Dis 1 (1999) 229-236
51. Tran M.Q., Gohh R.Y., Morrissey P.E., et al. Cryptosporidium infection in renal transplant patients. Clin Nephrol 63 (2005) 305-309
52. Palau L.A., and Pankey G.A. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 57 (1997) 413-415
53. Sellin J.H. The pathophysiology of diarrhea. Clin Transplant 15 S (2001) 2-10
54. Keven K., Basu A., Re L., et al. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transplant Infect Dis 6 (2004) 10-14
55. Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf 24 (2001) 645-663
56. Knoll G.A., MacDonald I., Khan A., et al. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 14 (2003) 2381-2386